| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.074 | 0.1 |